PlainRecalls
No agency classActive

CPSC recall · Reported June 30, 2022

Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a…

Recall #
22754
Affected scope
About 9,000
Verify with CPSC →
View my saved recalls

Mohnark Pharmaceuticals Inc., of Davie, Fla. recalled The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The pr….

Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet… was recalled by Mohnark Pharmaceuticals Inc., of Davie, Fla. in June 30, 2022. Reason: The product contains lidocaine which must be in child resistant packaging as required by the Poison Preventio…. Remedy: Consumers should immediately stop using the recalled cream and store it in a location out…. Verify recall #22754 with the CPSC before acting.

The recall

Mohnark Pharmaceuticals Inc., of Davie, Fla. issued this CPSC recall-The product contains lidocaine which must be in child resistant packaging as required by the Poison Preventio….

None
agency class
June 30, 2022
reported

Sourced from official CPSC enforcement records. Verify recall #22754 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. Consumers holding this product should act on the agency's documented remedy above rather than relying on general guidance.

Within the same product category the archive holds 6 closely related recalls, 5 from CPSC - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Children & Baby Products recalls over time

Where this recall sits in its category - 3,781 children & baby products recalls on record

0100200300400500600 20052008201120142017202020232026 196

Product description

The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.

Reason for recall

The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.

Remedy, what to do

Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.

Recall Profile

Structured summary of the CPSC recall record
Attribute Value
Agency U.S. Consumer Product Safety Commission
Severity class Not classified by agency
Status Active
Recall number 22754
Date reported June 30, 2022
Date initiated June 30, 2022
Recalling firm Mohnark Pharmaceuticals Inc., of Davie, Fla.
Affected scope About 9,000
Distribution Not disclosed
Official source CPSC notice →

Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.

What to do with this recall

Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact…

  • Check the recall number (22754) and product description against the item you own. Search the archive
  • Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.. Recalled by Mohnark Pharmaceuticals Inc., of Davie, Fla.. Units affected: About 9,000.
Why was this product recalled?
The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.
What should consumers do?
Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.
Which agency issued this recall?
This recall was issued by the CPSC on June 30, 2022. CPSC does not publish a hazard classification for this recall. Recall number: 22754.
How do I report an injury from a recalled product?
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.

Nationwide recalls with similar severity or category timing

Consumer-product notices outside this firm and state, matched by severity timing and product category.

Compare this recall with CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per … → · All Children & Baby Products recalls

This recall: CPSC, reported June 30, 2022. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026